For more details, click here.
The application for the MTS 2021 Annual Congress Travel Grant is CLOSED!
A global statement on the new WHO Air Quality guidelines that were released on 22nd September 2021. The release of the guidelines is very important for the future lung health of people across the globe and the joint statement has garnered the support and endorsement of over 100 societies. The statement has now been published and is available here. The statement has also been published by International Journal of Public Health The press release can be viewed here .
MyHOUSE is a programme to encourage people to keep their houses smoke free. For further information, please go to their website at https://www.my-house.com.my/. To join the programme click here.
Six online CPD modules on COPD have been placed on the online platform MMA Medcomet. The modules were created by Novartis. Upon completion of each module, 1 CPD point will be granted instantly provided a 60% passing mark is obtained. Please click on this link to access the modules.
The Malaysian Thoracic Society wishes to thank all donors who contributed to the success of this donation. The following equipment has been donated:
1. 124 units of oxygen concentrators with consumables
2. 167 units of oxygen twinhead flowmeters
3. 10 units of oxygen regulator pin index with schrader valve
4. 10 units of palm pulse oximeters
5. 160 units of fingertip oximeters
6. 2 units of powered air purifying respirators
Click here for donor list
The MTS is part of a group of 200 World Lung Day (WLD) partners, organisations who care about lung health from all over the world who are helping raise awareness and make a difference.. Click here to read more
Four digital educational modules on lung cancer with the theme Conquering Lung Cancer Together which have been placed on an online platform called HealthPrez. Click here to read more
Donation by the Malaysian Thoracic Society to Ministry of Health Malaysia. Click here to read more
COPD is a major respiratory illness in Malaysia with a 4.7% prevalence of moderate to severe cases reported in 2018, which translates to 448,000 cases. Click here to read more